New implant could replace monthly shots for opioid addiction
NCT ID NCT07064564
First seen Feb 05, 2026 · Last updated May 22, 2026 · Updated 21 times
Summary
This study tests a new implant called iSTEP-N that releases naltrexone over many months to block the effects of opioids. It involves 33 healthy adults aged 18-55 who will receive either a low-dose implant, high-dose implant, or monthly injections of an approved medication. The goal is to see if the implant can provide steady drug levels and reduce the need for frequent shots.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.